STOCK TITAN

Delek US Holdings, Inc. Form 4 Filings

DK NYSE

Every Form 4 that Delek US Holdings, Inc. (DK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DK filings page.

Rhea-AI Summary

Delek US Holdings EVP and General Counsel Denise Clark McWatters reported routine equity compensation activity in company stock. On March 9 and 10, she received grants totaling 13,513 shares of common stock at no cost upon vesting of performance-based restricted stock units. In connection with these vestings, 11,606 shares were automatically withheld to cover tax obligations at prices of $40.13 and $40.64 per share, rather than sold on the open market. After these transactions, she directly holds 86,184 shares of Delek US Holdings common stock.

Rhea-AI Summary

Delek US Holdings EVP and CFO Mark Wayne Hobbs reported stock-based compensation activity involving the company’s common stock. On March 9–10, he acquired multiple share awards at no cash cost to him, including grants tied to the vesting of performance-based and time-vesting restricted stock units.

The filing also shows 6,388 shares were disposed of through share withholding to cover tax obligations upon vesting, rather than through open-market sales. After these transactions, Hobbs directly holds 125,149 shares of Delek US Holdings common stock.

Rhea-AI Summary

Delek US Holdings EVP Israel Joseph reported equity compensation-related transactions in company common stock. On March 6, he received 4,301 shares as a grant or award, tied to the vesting of performance-based restricted stock units. That same day, 1,693 shares were withheld at $42.29 per share to cover tax obligations on the vesting.

On March 9, an additional 353 shares were withheld at $40.13 per share for tax purposes. After these transactions, Joseph directly held 57,878 shares of Delek US common stock. The dispositions reflect tax-withholding mechanics rather than open-market sales.

Rhea-AI Summary

Delek US Holdings director Ezra Uzi Yemin reported open-market sales of Delek common stock. On March 4, 2026, he sold 18,139 directly owned shares at a weighted average price of $43.17 per share, leaving 240,281 shares held directly.

On the same date, 66,511 shares were sold indirectly through Yemin Investments, LP at the same weighted average price, with 613,145 shares remaining held indirectly. The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on December 3, 2025, using multiple trades between $43.00 and $43.57 per share.

Rhea-AI Summary

Delek US Holdings director Zohar Shlomo reported open‑market sales of company common stock under a pre‑arranged trading plan. On March 4–5, 2026, he sold a total of 29,372 shares of Delek US Holdings common stock in several transactions at prices between $43.00 and $45.50 per share. Following these sales, he directly owned 18,989 shares of the company’s common stock. The filing notes that these transactions were made pursuant to a Rule 10b5‑1 trading plan adopted on November 13, 2025, intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c).

Rhea-AI Summary

Delek US Holdings EVP Israel Joseph reported an open-market sale of 38,000 shares of common stock on March 4, 2026 at a weighted average price of $40.65 per share. After this transaction, he directly owned 55,623 shares of Delek US common stock.

The reported price reflects multiple trades with individual sale prices ranging from $40.10 to $40.93 per share, aggregated into a single weighted average figure for disclosure.

Rhea-AI Summary

Delek US Holdings, Inc. executive vice president of special projects Reuven Spiegel reported an open-market sale of common stock. On March 4, 2026, he sold 20,000 shares at a weighted average price of $42.84 per share, in multiple trades between $42.80 and $42.98. After this sale, he directly owned 48,530 shares of Delek US common stock.

Rhea-AI Summary

Delek US Holdings, Inc. director William J. Finnerty sold 5,392 shares of common stock in an open‑market transaction at $42.75 per share on March 4, 2026, leaving him with 46,369 directly owned shares after the sale.

Rhea-AI Summary

Delek US Holdings, Inc. President & CEO Avigal Soreq reported selling a total of 50,000 shares of common stock on March 3, 2026 in three open-market transactions. The weighted average sale prices were $41.71, $40.90, and $39.85 per share, each reflecting multiple trades within stated price ranges. These transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025. After these sales, Soreq directly holds 251,678 shares of Delek US common stock.

Rhea-AI Summary

A director of Delek US Holdings, Inc. reported acquiring 103,701 shares of common stock on 02/27/2026 through a transaction coded “M” at a price of $38.11 per share. After this transaction, the director directly owns 258,420 shares and indirectly holds 679,656 shares through Yemin Investments.

Rhea-AI Summary

Delek US Holdings President & CEO Avigal Soreq reported equity award activity involving the company’s common stock. On February 27, 2026, he acquired 186,666 shares through the exercise or conversion of a derivative security at $38.11 per share.

On the same date, 73,466 shares were disposed of at $38.11 per share as a tax-withholding disposition, with a footnote stating the shares were withheld to satisfy taxes upon vesting of equity awards. After these transactions, Soreq directly owned 301,678 common shares.

Rhea-AI Summary

Delek US Holdings EVP and CFO Mark Wayne Hobbs reported a mix of equity transactions in company common stock. He acquired 75,999 shares through an exercise or conversion of derivative securities at $38.11 per share. On the same date, 30,009 shares were disposed of in a transaction coded as tax withholding, at the same price, with a footnote stating these shares were withheld for tax purposes upon vesting of equity awards. After these transactions, his directly held ownership was reported as 111,873 common shares.

Rhea-AI Summary

Delek US Holdings EVP Robert G. Wright reported equity compensation activity involving the company’s common stock. On February 27, 2026, he acquired 35,550 shares of common stock at $38.11 per share through the exercise or conversion of a derivative security. On the same date, 14,110 shares of common stock were disposed of at $38.11 per share to satisfy tax obligations, with the filing noting these shares were withheld for tax purposes upon vesting of equity awards, rather than sold in the open market. After these transactions, Wright directly owned 52,421 common shares of Delek US Holdings.

Rhea-AI Summary

Delek US Holdings executive vice president of special projects Reuven Spiegel reported paired equity award transactions in common stock. He exercised or converted derivative awards into 79,998 shares at $38.11 per share, then had 31,579 shares withheld to cover taxes, leaving 68,530 shares held directly.

Rhea-AI Summary

Delek US Holdings executive Denise Clark McWatters, EVP, General Counsel and Corporate Secretary, exercised derivative equity awards into 52,221 shares of common stock at $38.11 per share. On the same day, 20,673 shares were disposed of to satisfy tax withholding obligations, leaving her with 84,277 shares of directly owned common stock.

Rhea-AI Summary

Delek US Holdings EVP Israel Joseph exercised derivative awards and had shares withheld for taxes. He acquired 71,109 shares of common stock at $38.11 per share through an option exercise, then 27,982 shares were disposed of to satisfy tax obligations, leaving him with 93,623 directly owned shares.

Rhea-AI Summary

Delek US Holdings, Inc. executive Israel Joseph, an EVP, reported a tax-related share transaction. On 02/11/2026, 2,826 shares of common stock were disposed of at $34.52 per share as shares were withheld for tax purposes upon vesting of equity awards. Following this tax-withholding disposition, Joseph directly beneficially owned 51,534 shares of Delek US common stock.

Rhea-AI Summary

Delek US Holdings, Inc. executive reports routine share withholding for taxes. An executive vice president of Delek US Holdings, Inc. filed a Form 4 disclosing that on 12/10/2025, 1,382 shares of common stock were disposed of at a price of $34.57 per share. After this transaction, the reporting person directly beneficially owned 37,584 shares of Delek US common stock. The filing notes that the shares were withheld for tax purposes upon the vesting of equity awards, which is a common administrative transaction related to executive compensation.

Rhea-AI Summary

Delek US Holdings, Inc. executive vice president, Special Projects, reported a routine equity transaction. On 12/10/2025, the insider had 2,909 shares of common stock withheld at a price of $34.57 per share. The filing notes these shares were withheld for tax purposes upon the vesting of equity awards, meaning the insider did not execute an open-market sale.

After this withholding, the executive directly owned 20,111 shares of Delek US Holdings common stock. This kind of transaction is a standard administrative step tied to equity compensation rather than a discretionary buy or sell decision.

Rhea-AI Summary

Delek US Holdings, Inc. reported an insider share transaction by its President & CEO and Director on a Form 4. On 12/10/2025, 5,041 shares of common stock were disposed of at $34.57 per share under transaction code F, which the filing explains represents shares withheld for tax purposes upon vesting of equity awards, rather than an open-market sale. Following this tax withholding event, the reporting person directly beneficially owned 188,478 shares of Delek US common stock.

Rhea-AI Summary

Delek US Holdings, Inc. executive reports routine share withholding for taxes. A company officer, serving as EVP, General Counsel and Corporate Secretary, reported a transaction in Delek US Holdings common stock dated 12/10/2025. The Form 4 shows that 2,646 shares of common stock were disposed of at a price of $34.57 per share, identified as shares withheld for tax purposes upon the vesting of equity awards. Following this tax-related withholding, the reporting person directly owns 52,729 shares of Delek US Holdings common stock.

Rhea-AI Summary

Delek US Holdings, Inc. executive reports tax-related share withholding

An executive vice president of Delek US Holdings, Inc. (DK) reported a routine change in ownership of company stock. On 12/10/2025, 1,401 shares of common stock were disposed of at a price of $34.57 per share in a transaction coded "F," which indicates shares were withheld by the company to cover taxes due upon vesting of equity awards. After this tax withholding, the reporting person directly beneficially owns 54,360 shares of Delek US common stock.

Rhea-AI Summary

Delek US Holdings, Inc. executive vice president and chief financial officer reported an automatic share withholding related to equity compensation. On 12/10/2025, 1,070 shares of common stock were disposed of at a price of $34.57 per share under transaction code “F,” which indicates shares withheld to cover taxes upon vesting of equity awards. After this tax withholding, the officer directly beneficially owned 44,478 shares of Delek US common stock. The filing is made by a single reporting person and does not report any derivative securities transactions.

Rhea-AI Summary

Delek US Holdings, Inc. executive vice president reported a routine equity transaction involving company stock. On 12/09/2025, 353 shares of common stock were disposed of at a price of $35.94 per share in a transaction coded "F," which indicates shares were withheld to cover taxes upon vesting of equity awards. After this tax withholding, the reporting person beneficially owned 55,408 shares of Delek US common stock directly. This filing reflects administrative management of equity compensation rather than an open-market buy or sell decision.

Rhea-AI Summary

Delek US Holdings (DK) reported an insider transaction by its EVP, Special Projects. On 11/11/2025, the officer sold 17,000 shares of common stock at a weighted average price of $41.42 and 10,000 shares at a weighted average price of $41.25. Following these sales, the reporting person beneficially owns 23,020 shares, held directly.

The filing notes the trades were executed under a Rule 10b5-1 trading plan adopted on March 6, 2025 and amended August 13, 2025. Price ranges were disclosed: $41.39–$41.59 for the first set and $41.16–$41.37 for the second.

Rhea-AI Summary

Delek US Holdings (DK) reported insider activity by EVP Joseph Israel. On 11/11/2025, he sold 20,028 shares of common stock at a weighted average price of $41.115 (range: $40.935–$41.26). The same day, 2,652 shares were withheld for taxes upon equity award vesting at $41.70. On 11/12/2025, he sold an additional 4,380 shares at a weighted average price of $40.942 (range: $40.60–$41.11).

Following these transactions, Israel directly beneficially owned 55,761 shares.

Rhea-AI Summary

Delek US Holdings (DK): EVP insider sale reported. An executive vice president sold 5,643 shares of common stock on 11/11/2025 at a weighted average price of $41.462, with trades ranging from $41.45 to $41.51, leaving 41,269 shares directly owned after this transaction. On 11/12/2025, the EVP sold an additional 2,303 shares at a weighted average price of $40.427, with trades ranging from $40.37 to $40.48, resulting in 38,966 shares directly owned afterward.

Rhea-AI Summary

Delek US Holdings (DK) reported an insider transaction on a Form 4. Director Ezra Uzi Yemin sold common stock on 11/07/2025 pursuant to a Rule 10b5-1 plan. Two sales were reported at a weighted average price of $43.09, reflecting multiple trades between $43.00 and $43.39 per share.

Following these transactions, beneficial ownership stands at 154,719.047 shares direct and 679,656 shares indirect held by Yemin Investments, LP.

Rhea-AI Summary

Delek US Holdings (DK): Form 4 insider transaction. Director Ezra Uzi Yemin reported open‑market sales of common stock on 10/29/2025. He sold 1,581 shares at a weighted average price of $38.08 and, through Yemin Investments, LP, sold 5,807 shares at the same weighted average price.

Following these transactions, beneficial ownership stood at 166,580.047 shares held directly and 723,145 shares held indirectly by Yemin Investments, LP. The trades were made pursuant to a Rule 10b5‑1 plan. The reported price reflects a weighted average of multiple sales ranging from $38.00 to $38.30 per share, with full breakdowns available upon written request.

Rhea-AI Summary

Delek US Holdings (DK): Director Ezra Uzi Yemin reported open‑market sales made pursuant to a Rule 10b5‑1 plan. On 10/23/2025, he sold 7,249 shares of common stock at a weighted average price of $38.04 (direct) and 26,578 shares at $38.04 (indirect via Yemin Investments, LP). On 10/24/2025, he sold 20,982 shares at $38.16 (direct) and 76,927 shares at $38.16 (indirect). On 10/27/2025, he sold 188 shares at $38.01 (direct) and 688 shares at $38.01 (indirect).

Following these transactions, beneficial ownership stood at 168,161.047 shares direct and 728,952 shares indirect.